Donovan Joanne M. 4

What Happened
Joanne M. Donovan, Chief Medical Officer of Edgewise Therapeutics (EWTX), sold a total of 16,358 shares in open-market transactions on March 27, 2026. The filing reports an average price of $30.98 per share (sales executed at prices in the range $30.49–$31.68), generating aggregate proceeds of approximately $506,734. These were outright sales (not purchases or option exercises).

Key Details

• Transaction date: March 27, 2026; Form 4 filed March 30, 2026 (filed within the standard reporting window).
• Shares sold: 9,623 shares and 6,735 shares (total 16,358).
• Price(s): average $30.98; actual transaction prices ranged from $30.49 to $31.68.
• Proceeds: about $298,099 and $208,635 (total ≈ $506,734).
• Shares owned after the transaction: not specified in the provided filing.
• Notable footnotes: sales involved shares originally acquired through the Edgewise 2021 Employee Stock Purchase Plan on multiple purchase dates (May/Nov 2022, May/Nov 2023, May/Nov 2024); filing notes one lot includes 594 shares purchased Nov 17, 2025. The $30.98 figure is an average price; the reporting person can provide per-price allocations on request.

Context
These were routine open-market sales of ESPP-acquired shares by a company executive. Sales do not necessarily indicate a change in company outlook; purchases are generally considered a stronger signal of insider confidence. This transaction was reported on a timely Form 4.